India’s Biotech Sector Potential is USD 100 in Next Twelve Years; Study


February 11, 2013

India has a wealth of intellectual capital in biotechnology and healthcare to be developed, and its government is aiming to create a framework to develop it, according to The Hindu Business Line, which could be good news for private equity investors.


As a reference, the article points out that Singapore’s Tamasek doubled its assets under management by investing in high tech industries. India could emulate such strategy for the kind of investment involved in growing it biotech sector into a USD 100 billion one by 2025. (Image source: ABLE Indian Biotechnology Roadmap to the Next Decade and Beyond)

Share on FacebookTweet about this on TwitterShare on Google+Share on LinkedIn